Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 3, 2002 - Issue 6
Submit an article Journal homepage
73
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluation

Review of raloxifene and its clinical applications in osteoporosis

Oscar Gluck University of Arizona, Arizona Rheumatology Center, 6706 North 19th Avenue, Suite 201, Phoenix, AZ 85015, USA
&
Michael Maricic University of Arizona, Southern Arizona VA Healthcare System, 3601 South 6th Avenue, 1-11C2, Tucson, AZ 85723, USA. [email protected]
Pages 767-775 | Published online: 25 Feb 2005

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yongming Qu, Mayme Wong, Daniel Thiebaud & John L. Stock. (2005) The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial. Current Medical Research and Opinion 21:12, pages 1955-1959.
Read now

Articles from other publishers (14)

Edmund Charles Jenkins, Mrittika Chattopadhyay & Doris Germain. (2021) Folding Mitochondrial-Mediated Cytosolic Proteostasis Into the Mitochondrial Unfolded Protein Response. Frontiers in Cell and Developmental Biology 9.
Crossref
Li-Ping Zhou, Ka-Ying Wong, Hoi-Ting Yeung, Xiao-Li Dong, Hui-Hui Xiao, Amy G.-W. Gong, Karl W.-K. Tsim & Man-Sau Wong. (2018) Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro. Frontiers in Pharmacology 9.
Crossref
Javier Labad, Lourdes Martorell, Elena Huerta-Ramos, Jesús Cobo, Elisabet Vilella, Elena Rubio-Abadal, Gemma Garcia-Pares, Marta Creus, Cristian Núñez, Laura Ortega, Eva Miquel & Judith Usall. (2016) Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial. European Neuropsychopharmacology 26:10, pages 1683-1689.
Crossref
Judith Usall, Elena Huerta-Ramos, Javier Labad, Jesús Cobo, Christian Núñez, Marta Creus, Gemma García Parés, Daniel Cuadras, José Franco, Eva Miquel, Julio César Reyes & Mercedes Roca. (2016) Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial. Schizophrenia Bulletin 42:2, pages 309-317.
Crossref
Atul Kumar, Vishwa Deepak Tripathi, Promod Kumar, Lalit Prakash Gupta, Akanksha, Ritu Trivedi, Hemant Bid, V.L. Nayak, Jawed A. Siddiqui, Bandana Chakravarti, Ruchi Saxena, Anila Dwivedi, M.I. Siddiquee, U. Siddiqui, Rituraj Konwar & Naibedya Chattopadhyay. (2011) Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents. Bioorganic & Medicinal Chemistry 19:18, pages 5409-5419.
Crossref
Yukako Tabuchi, Yuko Ando, Hidemi Kanemura, Ikuo Kawasaki, Takahiro Ohishi, Masao Koida, Ryo Fukuyama, Hiromichi Nakamuta, Shunsaku Ohta, Kiyoharu Nishide & Yoshitaka Ohishi. (2009) Preparation of novel (Z)-4-ylidenebenzo[b]furo[3,2-d][1,3]oxazines and their biological activity. Bioorganic & Medicinal Chemistry 17:11, pages 3959-3967.
Crossref
Yonghua Wang, Yan Li, Jun Ding, Yuan Wang & Yaqing Chang. (2008) Prediction of binding affinity for estrogen receptor α modulators using statistical learning approaches. Molecular Diversity 12:2, pages 93-102.
Crossref
Kevin D. Dykstra, Liangqin Guo, Elizabeth T. Birzin, Wanda Chan, Yi Tien Yang, Edward C. Hayes, Carolyn A. DaSilva, Lee-Yuh Pai, Ralph T. Mosley, Bryan Kraker, Paula M.D. Fitzgerald, Frank DiNinno, Susan P. Rohrer, James M. Schaeffer & Milton L. Hammond. (2007) Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα. Bioorganic & Medicinal Chemistry Letters 17:8, pages 2322-2328.
Crossref
Ana Paula V. Dantas & Kathryn Sandberg. (2005) Challenges and opportunities associated with targeting estrogen receptors in treating hypertension and cardiovascular disease. Drug Discovery Today: Therapeutic Strategies 2:3, pages 245-251.
Crossref
Philippe Orcel. (2005) Ostéoporose post-ménopausique : traiter aujourd'hui et demain. Revue du Rhumatisme 72, pages S10-S15.
Crossref
Subhendu Mukherjee, Achintya Saha & Kunal Roy. (2005) QSAR of estrogen receptor modulators: exploring selectivity requirements for ERα versus ERβ binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters. Bioorganic & Medicinal Chemistry Letters 15:4, pages 957-961.
Crossref
P Cozzini & T Dottorini. (2004) Is it possible docking and scoring new ligands with few experimental data? Preliminary results on estrogen receptor as a case study. European Journal of Medicinal Chemistry 39:7, pages 601-609.
Crossref
Jinn-Moon Yang & Tsai-Wen Shen. (2004) A pharmacophore-based evolutionary approach for screening estrogen receptor antagonists. A pharmacophore-based evolutionary approach for screening estrogen receptor antagonists.
George D. Hartman & Robert S. Meissner. 2004. 67 78 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.